| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Dec 3, 2025 | Spyre Therapeutics, Inc. | CEO | Sell | 38.8 | -15,000 | -2.14% | ✓ | $435.4K |
| Nov 3, 2025 | Nov 5, 2025 | Spyre Therapeutics, Inc. | CEO | Sell | 27.5 | -45,000 | -6.02% | ✓ | $1M |
| Dec 28, 2020 | Dec 29, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 5.0 | -19,500 | -60.81% | ✓ | $1.4M |
| Nov 24, 2020 | Nov 25, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -5,000 | -16.59% | ✓ | $235.2K |
| Nov 5, 2020 | Nov 9, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -2,500 | -16.59% | ✓ | $105.1K |
| Sep 30, 2020 | Oct 2, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 7.5 | -14,500 | -53.57% | ✓ | $546.5K |
| Sep 18, 2020 | Sep 22, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -2,500 | -16.59% | ✓ | $105K |
| Sep 15, 2020 | Sep 16, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -2,500 | -16.59% | ✓ | $92.7K |
| Sep 11, 2020 | Sep 15, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 25.0 | -2,000 | -13.73% | ✓ | $70K |
| Jun 30, 2020 | Jul 2, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -10,000 | -50.45% | ✗ | $326.6K |
| Apr 27, 2020 | Apr 29, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -2,000 | -16.92% | ✓ | $64K |
| Apr 8, 2020 | Apr 10, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 10.0 | -8,000 | -44.89% | ✓ | $216.4K |
| Feb 11, 2020 | Feb 13, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 20.0 | -2,000 | -16.92% | ✓ | $74.6K |
| Jan 8, 2020 | Jan 10, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 7.5 | -12,807 | -56.59% | ✓ | $440.2K |